2024 Partners

Lead Partner

TIL 2024 Partner - Scale Ready


ScaleReady is a joint venture between Bio-Techne, Fresenius Kabi, and Wilson Wolf. Bringing together proven tools and technologies for cell culture, cell activation, gene editing, and cell processing, ScaleReady provides leading therapeutic developers with the most simple, scalable, and versatile manufacturing platform in the industry. Our platform includes G-Rex® cell culture technology, the Lovo and Cue cell processing systems, and a wide range of GMP proteins, reagents, media, and gene editing technologies.  


Expertise Partners

TIL 2024 Partner - Miltenyi

Miltenyi Biotec

Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative technologies enable solutions for cellular research, cell therapy, and cell manufacturing. Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer. Miltenyi Biotec has more than 4,000 employees in 28 countries.


TIL 2024 Partner - OBI

Biosharing Network

The market’s most experienced provider of IRRADIATED APHERESIS DERIVED FEEDER CELLS, the BioSharing Network is a partnership between eight US blood centers. The network has over two million donors and has decades of experience recruiting donors and performing apheresis procedures. Our network provides GMP (mobilized & non-mobilized) leukopacks, bone marrow, cord blood and perinatal tissue, as well as providing support services including flowcytometry, cryopreservation and prodigy-based manufacturing. With multiple donor rooms, clean rooms for manufacturing, and strong logistics teams, we are the most reliable provider in the market.


Program Partner

TIL 2024 Partner - CTMC


CTMC – a joint venture between MD Anderson Cancer Center and Resilience – was created to accelerate the development and manufacturing of impactful cell therapies for patients with cancer. Our strategic position within the Texas Medical Center, combined with our expertise in TIL and CAR-T development, manufacturing, and  regulatory, converge to enable an accelerated path to IND for cell therapies. By leveraging the strengths of MD Anderson and Resilience we start clinical trials faster and provide a clear path to robust commercialization.


Exhibition Partner

TIL 2024 Partner - Nanotein

Nanotein Technologies

Nanotein Technologies is a Berkely-based, Series-A biotechnology start-up manufacturing next generation reagents for expansion and activation of immune cells for Cell Therapy applications. Our technology is a fully soluble, protein scaffold with specific functional antibodies bound with a high-affinity linkage to the protein core.  This creates a highly effective protein-antibody product, for targeted and robust activation - taking advantage of receptor clustering biology for maximum impact. On the market today, we sell products for T cell and NK cell (feeder free!) activation and expansion.

We're a technical and collaborative team - small, but mighty - and would love for our reagents to help your cell therapy manufacturing process. We love to chat with potential customers, learn about your processes and help you optimize your workflows with our reagents. Send us a message or pick up some product to get started today!


Event Partner

TIL 2024 Partner - DLS

Discovery Life Sciences

Discovery Life Sciences is a leading provider of highly characterized human biospecimens and cellular starting materials integrated with expert multi-omic analytical services to advance cell and gene therapy and precision medicine programs for cancer, infectious disease, and other complex conditions.  Our AllCells® RUO and GMP products have supported many complex cell and gene therapy programs transition seamlessly from early discovery to process development and manufacturing, with an average 98% collection deliverability rate.